Interleukin 8 is a biomarker of telomerase inhibition in cancer cells

BACKGROUND: Telomerase activity is required for both initiation and maintenance of tumorigenesis and over 90% cancers overexpress telomerase. Therefore, telomerase targeting has emerged as a potential strategy for cancer treatment. In agreement with this, several telomerase inhibitors are being test...

Descripción completa

Detalles Bibliográficos
Autores principales: Solomon, Peter, Dong, Yuying, Dogra, Shaillay, Gupta, Romi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038317/
https://www.ncbi.nlm.nih.gov/pubmed/29986697
http://dx.doi.org/10.1186/s12885-018-4633-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038317/
https://www.ncbi.nlm.nih.gov/pubmed/29986697
http://dx.doi.org/10.1186/s12885-018-4633-x

Ejemplares similares